A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
F cells measure the presence of fetal hemoglobin, a heritable quantitative trait in adults that accounts for substantial phenotypic diversity of sickle cell disease and beta thalassemia. We applied a genome-wide association mapping strategy to individuals with contrasting extreme trait values and mapped a new F cell quantitative trait locus to BCL11A, which encodes a zinc-finger protein, on chromosome 2p15. The 2p15 BCL11A quantitative trait locus accounts for 15.1% of the trait variance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BCL11A is a repressor of HbF gene expression.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [14]
Citations
Cites
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Population Structure and Eigenanalysis
Patterson, N., Price, A. L., & Reich, D. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020190 · Cited by 5,280
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
A General Test of Association for Quantitative Traits in Nuclear Families
Abecasis, G. R., Cardon, L. R., & Cookson, W. O. C. (2000) · The American Journal of Human Genetics · doi:10.1086/302698 · Cited by 1,126
Disorders of hemoglobin genetics, pathophysiology, and clinical management
Steinberg, M. H. (2001) · Cited by 438
Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management
Somervaille, T. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401119 · Cited by 432
Bcl11a is essential for normal lymphoid development
Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351
Thein, S. L., Menzel, S., Peng, X., Best, S., Jiang, J., Close, J., Silver, N., Gerovasilli, A., Ping, C., Yamaguchi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611393104 · Cited by 314
Self-citationGenetic influences on F cells and other hematologic variables: a twin heritability study
Garner, C., Tatu, T., Reittie, J. E., Littlewood, T., Darley, J., Cervino, S., Farrall, M., Kelly, P., Spector, T. D., & Thein, S. L. (2000) · Blood · doi:10.1182/blood.v95.1.342 · Cited by 274
Self-citationRegulation of human fetal hemoglobin: new players, new complexities
Bank, A. (2006) · Blood · doi:10.1182/blood-2005-05-2113 · Cited by 209
Cited by
Items 301–400 of 534
Targeting fetal hemoglobin expression to treat β hemoglobinopathies
Steinberg, M. H. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2066519 · Cited by 19
The role of molecular diagnostic testing for hemoglobinopathies and thalassemias
Sabath, D. E. (2023) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.14089 · Cited by 17
Dadheech, S., MadhuLatha, D. M., Jainc, S., Joseph, J., Jyothy, A., & Munshi, A. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.184285 · Cited by 20
Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies
Bauer, D. E., Brendel, C., & Fitzhugh, C. D. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.08.014 · Cited by 15
Fanis, P., Kousiappa, I., Phylactides, M., Kyrri, A. R., Hadjigavriel, M., Christou, S., Sitarou, M., & Kleanthous, M. (2019) · Human Mutation · doi:10.1002/humu.23817 · Cited by 16
Current and future gene therapies for hemoglobinopathies
Brendel, C., & Williams, D. A. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000581 · Cited by 15
Biswas, S., Nag, A., Ghosh, K., Ray, R., Roy, K., Bandyopadhyay, A., & Bhattacharyya, M. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3536-x · Cited by 17
Small molecule therapeutics to treat the β-globinopathies
Yu, L., Myers, G., & Engel, J. D. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000579 · Cited by 16
Petruzzelli, R., Gaudino, S., Amendola, G., Sessa, R., Puzone, S., Concilio, R. D., D’Urzo, G., Amendolara, M., Izzo, P., & Grosso, M. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08303.x · Cited by 17
GWAS to Therapy by Genome Edits?
Hardison, R. C., & Blobel, G. A. (2013) · Science · doi:10.1126/science.1245813 · Cited by 15
Rivers, A. E., Jagadeeswaran, R., & Lavelle, D. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00440.2017 · Cited by 14
Kuo, K. H. M. (2017) · Genomics Insights · doi:10.1177/1178631017721178 · Cited by 17
Pharmacologic induction of PGC ‐1α stimulates fetal haemoglobin gene expression
Sun, Y., Habara, A. H., Le, C. Q., Nguyen, N., Chen, R., Murphy, G. J., Chui, D. H. K., Steinberg, M. H., & Cui, S. (2022) · British Journal of Haematology · doi:10.1111/bjh.18042 · Cited by 14
Al-Allawi, N. A. S., Qadir, S. M. A., Puehringer, H., Chui, D. H. K., Farrell, J. J., & Oberkanins, C. (2018) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12927 · Cited by 16
Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients
Al-Allawi, N. A. S., Puehringer, H., Raheem, R. A., & Oberkanins, C. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0310 · Cited by 17
Transcriptional Repressor BCL11A in Erythroid Cells
Zheng, G., & Orkin, S. H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_9 · Cited by 15
Adelvand, P., Hamid, M., & Sardari, S. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1406795 · Cited by 14
Predictive SNPs for β0-thalassemia/HbE disease severity
Munkongdee, T., Tongsima, S., Ngamphiw, C., Wangkumhang, P., Peerapittayamongkol, C., Hashim, H., Fucharoen, S., & Svasti, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89641-2 · Cited by 17
Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease
Bhatt, S., Argueta, D. A., Gupta, K., & Kundu, S. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0348 · Cited by 15
Gil, G. P., Ananina, G., Oliveira, M. B., Costa, F. F., da Silva, M. J., Santos, M. N. N., Bezerra, M. A. C., Hatzlhofer, B. L. D., Araujo, A. S., & de Melo, M. B. (2013) · Hemoglobin · doi:10.3109/03630269.2013.789438 · Cited by 15
Tall, F. G., Martin, C., Ndour, E. H. M., Renoux, C., Ly, I. D., Connes, P., Guéye, P. M., Diallo, R. N., Diagne, I., Diop, P. A., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27934 · Cited by 13
Cui, J., Azimi, M., Baysdorfer, C., Vichinsky, E. P., & Hoppe, C. C. (2013) · Hemoglobin · doi:10.3109/03630269.2013.782461 · Cited by 14
Ali, H., Iftikhar, F., Shafi, S., Siddiqui, H. L., Khan, I. A., Choudhary, M. I., & Musharraf, S. G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.027 · Cited by 15
Heterogeneity of fetal hemoglobin production in adult red blood cells
Khandros, E., & Blobel, G. A. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000640 · Cited by 13
Ali, H., Khan, F., & Musharraf, S. G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114612 · Cited by 13
Enhancer-Mediated Formation of Nuclear Transcription Initiation Domains
Gibbons, M. D., Fang, Y., Spicola, A. P., Linzer, N., Jones, S. M., Johnson, B. R., Li, L., Xie, M., & Bungert, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169290 · Cited by 14
Ibañez, V., Vaitkus, K., Zhang, X., Jagadeeswaran, R., Rivers, A. E., Saunthararajah, Y., Molokie, R. E., & Lavelle, D. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009558 · Cited by 12
Huo, Y., McConnell, S. C., Liu, S., Zhang, T., Yang, R., Ren, J., & Ryan, T. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05547.x · Cited by 12
Fornari, T. A., Lanaro, C., de Albuquerque, D. M., Ferreira, R., & Costa, F. F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216668052 · Cited by 12
HMGA2 Moderately Increases Fetal Hemoglobin Expression in Human Adult Erythroblasts
de Vasconcellos, J. F., Lee, Y. T., Byrnes, C., Tumburu, L., Rabel, A., & Miller, J. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166928 · Cited by 13
Physiological and Aberrant γ-Globin Transcription During Development
Barbarani, G., Łabędź, A., Stucchi, S., Abbiati, A., & Ronchi, A. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640060 · Cited by 17
Prime editing: A potential treatment option for β‐thalassemia
Arif, T., Farooq, A., Ahmad, F. J., Akhtar, M., & Choudhery, M. S. (2022) · Cell Biology International · doi:10.1002/cbin.11972 · Cited by 14
Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia
Eridani, S., & Mosca (2011) · Journal of Blood Medicine · doi:10.2147/jbm.s14942 · Cited by 13
Wonkam, A., Esoh, K. K., Levine, R. M., Bitoungui, V. J. N., Mnika, K., Nimmagadda, N., Dempsey, E., Nkya, S. W., Sangeda, R. Z., Nembaware, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57413-5 · Cited by 12
Human genetics implicates a BACH2–NRF2 axis in fetal haemoglobin activation
Guo, C., Arora, U. P., Cheng, X., Xu, W., Cato, L. D., Li, R., Lu, H. Y., Lee, A., Yu, F., Agarwal, G., et al. (2026) · Nature · doi:10.1038/s41586-026-11113-2 · Cited by 11
Genetic Factors Modifying Sickle Cell Disease Severity
Gardner, K., & Thein, S. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_15 · Cited by 14
Self-citationAn in vivo model for analysis of developmental erythropoiesis and globin gene regulation
McColl, B., Kao, B., Lourthai, P., Chan, K., Wardan, H., Roosjen, M., Delagneau, O., Gearing, L. J., Blewitt, M. E., Svasti, S., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-246637 · Cited by 12
Creary, L. E., McKenzie, C. A., Menzel, S., Hanchard, N. A., Taylor, V., Hambleton, I. R., Spector, T. D., Forrester, T. E., & Thein, S. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07532.x · Cited by 11
Self-citationInfluences of Genetic Variation on Fetal Hemoglobin
He, Y., Lin, W., & Luo, J. (2011) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2011.616573 · Cited by 12
Engineering Globin Gene Expression
Davis, R., Gurumurthy, A., Hossain, M. A., Gunn, E. M., & Bungert, J. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.004 · Cited by 11
Carrocini, G. C. S., Venâncio, L. P. R., & Bonini-Domingos, C. R. (2015) · Evolutionary Bioinformatics · doi:10.4137/ebo.s15364 · Cited by 11
Genetic control of erythropoiesis
Tumburu, L., & Thein, S. L. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000333 · Cited by 16
Self-citationBao, E. L., Lareau, C. A., Brugnara, C., Fulcher, I., Barau, C., Moutereau, S., Habibi, A., Badaoui, B., Berkenou, J., Bartolucci, P., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25421 · Cited by 10
Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease
Araújo, A. D. S., Pinto, A. C. S., Lobo, C. L. D. C., Figueiredo, M. S., Gualandro, S. F. M., Saad, S. T. O., & Cançado, R. D. (2023) · Hemoglobin · doi:10.1080/03630269.2023.2211771 · Cited by 14
Innovative Therapies for Hemoglobin Disorders
Sii-Felice, K., Nègre, O., Brendel, C., Tubsuwan, A., Morel-à-l’Huissier, E., Filardo, C., & Payen, E. (2020) · BioDrugs · doi:10.1007/s40259-020-00439-6 · Cited by 10
Blobel, G. A., Bodine, D., Brand, M., Crispino, J., de Bruijn, M. F. T. R., Nathan, D., Papayannopoulou, T., Porcher, C., Strouboulis, J., Zon, L., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.06.008 · Cited by 9
“Following important, large-scale genetic studies, including those from Swee Lay Thein that identified the major quantitative trait loci governing the levels of fetal hemoglobin, it emerged that the locus encoding BCL11A plays an important role in g-globin gene repression during development [62].”
Akbulut-Jeradi, N., Fernandez, M., Khaldi, R. A., Sukumaran, J., & Adekile, A. D. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060567 · Cited by 10
Hantaweepant, C., Suktitipat, B., Pithukpakorn, M., Chinthammitr, Y., Limwongse, C., Tansiri, N., Sawatnatee, S., Takpradit, C., Rotchanapanya, W., Pongudom, S., et al. (2023) · Hematology · doi:10.1080/16078454.2023.2187155 · Cited by 9
Sickle cell disease in the era of precision medicine: looking to the future
Steinberg, M. H., Kumar, S. S., Murphy, G. J., & Vanuytsel, K. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1688658 · Cited by 9
Papadopoulos, P., Kafasi, A., Cuyper, I. M. D., Barroca, V., Lewandowski, D., Kadri, Z., Veldthuis, M., Berghuis, J., Gillemans, N., Cuesta, C. B., et al. (2020) · Human Genomics · doi:10.1186/s40246-020-00283-3 · Cited by 9
CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects
Sahu, S., Poplawska, M., Lim, S. H., & Dutta, D. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122165 · Cited by 10
Emerging cellular and gene therapies for congenital anemias
Ludwig, L. S., Khajuria, R. K., & Sankaran, V. G. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31529 · Cited by 11
Quantitative Trait Loci Influencing Hb F Levels in Southern Thai Hb E (HBB: c.79G>A) Heterozygotes
Kesornsit, A., Jeenduang, N., Horpet, D., Plyduang, T., & Nuinoon, M. (2018) · Hemoglobin · doi:10.1080/03630269.2018.1429281 · Cited by 11
Omics Studies in Hemoglobinopathies
Katsantoni, E. Z. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00386-1 · Cited by 10
Nuclear Factors That Regulate Erythropoiesis
Blobel, G. A., & Weiss, M. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.008 · Cited by 9
From Genetic Association to Genetic Switch
Michelson, A. M. (2008) · Science · doi:10.1126/science.1169216 · Cited by 9
Genome Editing for the β-Hemoglobinopathies
Porteus, M. H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-7299-9_8 · Cited by 8
Stephanou, C., Menzel, S., Philipsen, S., & Kountouris, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111408 · Cited by 9
Self-citationStructural insights into the DNA-binding mechanism of BCL11A: The integral role of ZnF6
Viennet, T., Yin, M., Jayaraj, A., Kim, W., Sun, Z.-Y. J., Fujiwara, Y., Zhang, K., Seruggia, D., Seo, H., Dhe‐Paganon, S., et al. (2024) · Structure · doi:10.1016/j.str.2024.09.022 · Cited by 8
CRISPR-based gene therapy for the induction of fetal hemoglobin in sickle cell disease
McManus, M. P., Frangoul, H., & Steinberg, M. H. (2024) · Expert Review of Hematology · doi:10.1080/17474086.2024.2429605 · Cited by 10
Key Pharmacogenomic Considerations for Sickle Cell Disease Patients
Κολλιοπούλου, Α., Στρατόπουλος, Α., Siamoglou, S., Sgourou, A., Ali, B. R., Papachatzopoulou, A., Κάτσιλα, Θ., & Patrinos, G. P. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0058 · Cited by 8
The Influence of Polymorphisms in Disease Severity in β-Thalassemia
Mohammadi-Asl, J., Ramezani, A., Norozi, F., Alghasi, A., Asnafi, A. A., Jaseb, K., & Saki, N. (2015) · Biochemical Genetics · doi:10.1007/s10528-015-9687-8 · Cited by 9
β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies
Barbarani, G., Łabędź, A., & Ronchi, A. E. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.571239 · Cited by 10
Eos Negatively Regulates Human γ-globin Gene Transcription during Erythroid Differentiation
Yu, H., Zhao, H.-L., Wu, Z., & Zhang, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022907 · Cited by 11
Do genome-wide association scans have potential for translation?
Lopes, M. C., Zeggini, E., & Panoutsopoulou, K. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.748 · Cited by 9
Hematopoietic stem cell therapy with gene modification to treat sickle cell disease
Ball, J., Bradley, A., Le, A., Tisdale, J. F., & Uchida, N. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf042 · Cited by 8
Hart, K. L., Liu, B., Brown, D., Campo-Fernández, B., Tam, K., Orr, K., Hollis, R. P., Brendel, C., Williams, D. A., & Kohn, D. B. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101254 · Cited by 9
Martyn, G. E., Doerfler, P. A., Yao, Y., Quinlan, K. G. R., Weiss, M. J., & Crossley, M. (2024) · Journal of sickle cell disease. · doi:10.1093/jscdis/yoae008 · Cited by 10
Mejri, A., Siala, H., Ouali, F., Bibi, A., & Messaoud, T. B. (2012) · Gene · doi:10.1016/j.gene.2012.06.078 · Cited by 7
Role Of Stem Cell Factor In The Reactivation Of Human Fetal Hemoglobin
Gabbianelli, M., & Testa, U. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.009 · Cited by 7
Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults
Jouini, L., Bibi, A., Ouali, F., Fredj, S. H., Ouennich, F., Siala, H., Messaoud, T. B., & Fattoum, S. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1253-9 · Cited by 11
Chan, N. C. N., Lau, K., Cheng, K. C. K., Chan, N. P. H., & Ng, M. H. L. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1245198 · Cited by 8
Hossain, M. A., Shen, Y., Knudson, I. J., Thakur, S., Stees, J. R., Qiu, Y., Pace, B. S., Peterson, K. R., & Bungert, J. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.85 · Cited by 9
Advancing the care of β-thalassaemia patients with novel therapies.
Bou‐Fakhredin, R., Motta, I., & Cappellini, M. D. (2022) · Blood transfusion · doi:10.2450/2021.0265-21 · Cited by 10
Priorities for sickle cell disease global research and implementation
Wonkam, A., Munung, N. S., Guindo, A., & Nnodu, O. E. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01400-4 · Cited by 7
de la Torre, L. D. C. R., Borrayo-LóPez, F. J., Perea, F. J., Aquino, E., Venegas, M., Hernández-Carbajal, C., Espinoza-Mata, L. L., & Ibarra‐Cortés, B. (2022) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmac073 · Cited by 7
Sales, R. R., Nogueira, B. L., Belisário, A. R., Faria, G., Mendes, F. G., Viana, M. B., & Luizon, M. R. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01079-0 · Cited by 8
Karkashon, S., Raghupathy, R., Bhatia, H., Dutta, A., Hess, S. Y., Higgs, J., Tifft, C. J., & Little, J. A. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.05.006 · Cited by 8
The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia
Amlie‐Lefond, C., Flanagan, J. M., Kanter, J., & Dobyns, W. B. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.06.004 · Cited by 11
Genome editing for blood disorders: state of the art and recent advances
Romito, M., Rai, R., Thrasher, A. J., & Cavazza, A. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20180147 · Cited by 7
Inhibition of γ/β Globin Gene Switching in CD 34+ Derived Erythroid Cells by BCL11A RNA Silencing
Taghavi, S. A., Hosseini, K. M., Tamaddon, G., & Kasraian, L. (2019) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-019-01131-8 · Cited by 7
Makino, T., Haruyama, M., Katayama, K., Terashima, H., Tsunemi, T., Miyazaki, K., Terakawa, M., Yamashiro, K., Yoshioka, R., & Maeda, H. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113717 · Cited by 8
Control of fetal globin expression in man: new opportunities to challenge past discoveries
Papayannopoulou, T. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.09.195 · Cited by 8
Kansal, R. (2025) · Genes · doi:10.3390/genes16111367 · Cited by 6
Ilboudo, Y., Brosseau, N., Lo, K. S., Belhaj, H., Moutereau, S., Marshall, K., Reid, M. E., Kutlar, A., Ashley‐Koch, A. E., Telen, M. J., et al. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf015 · Cited by 8
Phenotype-Genotype Correlation in β-Thalassemia
Galanello, R., Perseu, L., Satta, S., Demartis, F. R., & Campus, S. (2011) · Thalassemia Reports · doi:10.4081/thal.2011.s2.e6 · Cited by 11
Bach1 Inhibitor HPP-D Mediates γ-Globin Gene Activation in Sickle Erythroid Progenitors
Palani, C. D., Zhu, X., Alagar, M., Attucks, O. C., & Pace, B. S. (2023) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2023.102792 · Cited by 6
Mazzarini, M., Cherone, J. M., Nguyen, T., Martelli, F., Varricchio, L., Funnell, A. P. W., Papayannopoulou, T., & Migliaccio, A. R. (2024) · Stem Cells · doi:10.1093/stmcls/sxae049 · Cited by 6
Gene-environmental influence of space and microgravity on red blood cells with sickle cell disease
Igbineweka, N. E., & van Loon, J. J. W. A. (2024) · npj Genomic Medicine · doi:10.1038/s41525-024-00427-7 · Cited by 7
Milestones in the History of Hemoglobin Research (In Memory of Professor Titus H.J. Huisman)
Thein, S. L. (2011) · Hemoglobin · doi:10.3109/03630269.2011.613506 · Cited by 9
Self-citationRopero, P., Peral, M., Sánchez-Martínez, L. J., Rochas, S., Gómez-Álvarez, M., Nieto, J. M., González, F. A., Villegas, A., & Benavente, C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1347026 · Cited by 8
Tripathi, P., Agarwal, S., Mandal, K., Gupta, A., & Sarangi, A. N. (2023) · Thalassemia Reports · doi:10.3390/thalassrep13010009 · Cited by 7
TR4 and BCL11A repress γ-globin transcription via independent mechanisms
Wang, Y., Myers, G., Yu, L., Deng, K., Balbin-Cuesta, G., Singh, S. A., Guan, Y., Khoriaty, R. N., & Engel, J. D. (2024) · Blood · doi:10.1182/blood.2024024599 · Cited by 5
Abnormalities of the structure and synthesis of hemoglobin
Thein, S. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00009-2 · Cited by 8
Self-citationNathan, D. G. (2011) · Blood · doi:10.1182/blood-2011-08-370338 · Cited by 5
Mejri, A., Mansri, M., Fredj, S. H., Ouali, F., Bibi, A., Hafsia, R., Messaoud, T. B., & Siala, H. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1252386 · Cited by 5
Prasing, W., Mekki, C., Traisathit, P., Pissard, S., & Pornprasert, S. (2017) · Walailak Journal of Science and Technology (WJST) · doi:10.48048/wjst.2018.3151 · Cited by 9
Marshall, K., Howell, S., Badaloo, A. V., Reid, M. E., McFarlane‐Anderson, N., & McKenzie, C. A. (2018) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2018.08.001 · Cited by 5
New Deletion at Promoter of HBG1 Gene in Sickle Cell Disease Patients With High HbF Level
Chaouch, L., Sellami, H., Kalai, M., Darragi, I., Boudrigua, I., Chaouachi, D., Abbes, S., & Mnif, S. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001626 · Cited by 5
Theodorou, A., Phylactides, M., Katsantoni, E. Z., Vougas, K., Garbis, S. D., Fanis, P., Sitarou, M., Thein, S. L., & Kleanthous, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010134 · Cited by 5
Self-citation
Metadata
- Authors
- Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., Best, S., Spector, T. D., Farrall, M., Lathrop, M., & Thein, S. L.
- Affiliations
- King's College London (GB)
- University of California, Irvine (US)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- St Thomas' Hospital (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Thein, Swee Lay
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-09-02
- Volume
- 39
- Issue
- 10
- Pages
- 1197-1199
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2036308544
- Cited by
- 529
- References
- 16
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 22 · 2023: 27 · 2022: 24 · 2021: 34 · 2020: 43 · 2019: 25 · 2018: 33 · 2017: 27 · 2016: 37 · 2015: 27 · 2014: 25 · 2013: 26 · 2012: 20
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- fetal hemoglobin, F cells, quantitative trait loci, BCL11A, zinc finger proteins, sickle cell disease, beta-thalassemia, genome-wide association study
- MeSH terms
- Anemia, Sickle Cell, Carrier Proteins, Chromosome Mapping, Chromosomes, Human, Pair 2, Fetal Hemoglobin, Humans, Nuclear Proteins, Phenotype, Repressor Proteins, Genetic Variation, Genome, Human, Zinc Fingers, beta-Thalassemia, Quantitative Trait Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.